Table 1

Baseline characteristics of patients treated with DEVT vs IVT+EVT

Baseline characteristicsTotal (N=310)DEVT (n=241)IVT+EVT (n=69)P value
Age, mean±SD, years61.39±10.9261.63±11.4060.54±9.110.29
Male, n (%)240 (77.42)186 (77.18)54 (78.26)0.85
B-NIHSS, median (IQR)21 (11–27)21 (12–27)20 (9–27)0.68
Medical history, n (%)
 Atrial fibrillation30 (9.68)20 (8.30)10 (14.49)0.12
 Stroke/TIA80 (25.81)67 (27.80)13 (18.84)0.13
 CHD/MI35 (11.29)30 (12.45)5 (7.25)0.23
 Hypertension217 (70.00)167 (69.29)50 (72.46)0.61
 Diabetes70 (22.58)56 (23.24)14 (20.29)0.61
 Currently smoke142 (45.81)107 (44.40)35 (50.72)0.35
Previous antiplatelets, n (%)70 (22.58)60 (24.90)10 (14.49)0.07
Previous anticoagulant, n (%)10 (3.23)8 (3.32)2 (2.90)0.86
Occlusion location, n (%)0.74
 Distal BA42 (13.55)30 (12.45)12 (17.39)
 Middle BA99 (31.94)78 (32.37)21 (30.43)
 Proximal BA57 (18.39)44 (18.26)13 (18.84)
 V4112 (36.13)89 (36.93)23 (33.33)
PC-ASPECT, median (IQR)6 (5–8)6 (5–8)5 (4–7)0.08
BATMAN, median (IQR)6 (4–7)6 (3–7)6 (4–7)0.36
PC-CS, median (IQR)5 (2–6)5 (2–6)5 (3–7)0.14
Stroke aetiology, n (%)0.92
 Atherosclerotic251 (80.97)194 (80.50)57 (82.61)
 Cardioembolic44 (14.19)35 (14.52)9 (13.04)
 Other15 (4.84)12 (4.98)3 (4.35)
General anaesthesia, n (%)208 (70.27)164 (70.69)44 (68.75)0.76
  • P value for comparison between patients with DEVT and IVT+EVT treatment.

  • BA, basilar artery; BATMAN, Basilar Artery on Computed Tomography Angiography; B-NIHSS, Baseline National Institutes of Health Stroke Scale; CHD, coronary heart disease; DEVT, direct endovascular treatment; EVT, endovascular treatment; IVT, intravenous thrombolysis; MI, myocardial infarction; PC-ASPECT, Posterior Circulation Alberta Stroke Program Early Computed Tomography Score; PC-CS, Posterior Circulation Collateral Score; TIA, transient ischaemic attack.